ROIV

Roivant Sciences Ltd.CIK 1635088 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

$112.05M

34 trades · 4 insiders

Net · 90d

$-112.05M

Insiders on file

AI insights for ROIV PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for ROIV

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Venker Eric	President & Immunovant CEO	301	$0	$236.25M	2026-10-28
Epperly Melissa B,	Director	46	$0	$2.84M	2026-10-23
Oren Ilan	Director	43	$0	$0	2026-10-23
MOMTAZEE JAMES C	Director	44	$0	$0	2026-10-23
Gline Matthew	CEO, Director	91	$50.0K	$71.78M	2026-10-16
Sukhatme Mayukh	See Remarks	100	$0	$161.27M	2026-10-16
Torti Frank	President and Vant Chair	17	$0	$82.04M	2026-09-30
Humes Jennifer	Chief Accounting Officer	9	$0	$384.1K	2026-09-20
Pulik Richard	CHIEF FINANCIAL OFFICER	65	$0	$9.14M	2026-09-20
Gold Daniel Allen	Director	66	$0	$341.59M	2026-09-16
Fitzgerald Meghan	Director	36	$0	$4.27M	2026-09-16
MANCHESTER KEITH S	Director	51	$0	$258.62M	2026-09-16
QVT Financial LP	Other	45	$0	$300.69M	2026-06-30
Ramaswamy Vivek	Director	45	$0	$224.96M	2025-12-15
Kumar Rakhi	Chief Accounting Officer	97	$0	$9.87M	2025-02-20
SVF Investments (UK) Ltd	10% Owner	2	$0	$146.63M	2023-09-28
Sumitomo Chemical Co., Ltd.	10% Owner	1	$0	$130.00M	2023-06-22
Viking Global Equities Master Ltd.	10% Owner	4	$0	$128.70M	2023-06-22
Ott David C.	10% Owner	4	$0	$128.70M	2023-06-22
SoftBank Vision Fund L.P.	10% Owner	1	$0	$96.00M	2023-03-20
Oren Dan	10% Owner	1	$20.00M	$0	2022-11-10
Lo Andrew	Director	2	$0	$0	2022-09-15
Dexcel Pharma Technologies Ltd.	10% Owner	2	$155.0K	$0	2022-04-25

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Venker Eric	President & Immunovant CEO	S Sale	2026-10-28	2026-10-30	200,000	$36.59	$7.32M	1,199,154	SEC↗
Epperly Melissa B,	Director	F Tax w/h	2026-10-23	2026-10-27	116	$36.49	$4.2K	15,351	SEC↗
Epperly Melissa B,	Director	A Award	2026-10-23	2026-10-27	513	—	$0	15,467	SEC↗
Oren Ilan	Director	A Award	2026-10-23	2026-10-27	810	—	$0	124,490	SEC↗
MOMTAZEE JAMES C	Director	F Tax w/h	2026-10-23	2026-10-27	77	$36.49	$2.8K	112,265	SEC↗
MOMTAZEE JAMES C	Director	A Award	2026-10-23	2026-10-27	383	—	$0	112,342	SEC↗
Venker Eric	President & Immunovant CEO	S Sale	2026-10-20	2026-10-22	14,144	$35.42	$501.0K	1,399,154	SEC↗
Venker Eric	President & Immunovant CEO	S Sale	2026-10-20	2026-10-22	185,856	$35.09	$6.52M	1,413,298	SEC↗
Sukhatme Mayukh	President & CIO, Director	F Tax w/h	2026-10-16	2026-10-20	19,976	$33.53	$669.8K	18,563,884	SEC↗
Gline Matthew	CEO, Director	F Tax w/h	2026-10-16	2026-10-20	34,638	$33.53	$1.16M	16,549,136	SEC↗
Epperly Melissa B,	Director	M Exercise deriv	2026-10-01	2026-10-05	17,750	—	$0	151,416	SEC↗
Epperly Melissa B,	Director	S Sale	2026-10-01	2026-10-05	900	$36.57	$32.9K	14,954	SEC↗
Epperly Melissa B,	Director	S Sale	2026-10-01	2026-10-05	16,850	$36.08	$607.9K	15,854	SEC↗
Epperly Melissa B,	Director	M Exercise	2026-10-01	2026-10-05	17,750	$4.46	$79.2K	32,704	SEC↗
Sukhatme Mayukh	President & CIO, Director	F Tax w/h	2026-09-30	2026-10-02	46,879	$36.57	$1.71M	18,583,860	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise deriv	2026-09-30	2026-10-02	200,000	—	$0	3,644,834	SEC↗
Venker Eric	President & Immunovant CEO	S Sale	2026-09-30	2026-10-02	200,000	$36.62	$7.32M	1,599,154	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise	2026-09-30	2026-10-02	200,000	$3.85	$770.0K	1,799,154	SEC↗
Torti Frank	President and Vant Chair	F Tax w/h	2026-09-30	2026-10-02	40,309	$36.57	$1.47M	13,495,893	SEC↗
Gline Matthew	CEO, Director	F Tax w/h	2026-09-30	2026-10-02	76,171	$36.57	$2.79M	16,583,774	SEC↗
Pulik Richard	CFO	F Tax w/h	2026-09-20	2026-09-22	2,129	$39.77	$84.7K	269,681	SEC↗
Humes Jennifer	Chief Accounting Officer	F Tax w/h	2026-09-20	2026-09-22	3,880	$39.77	$154.3K	106,419	SEC↗
Pulik Richard	CFO	F Tax w/h	2026-09-20	2026-09-22	2,129	$39.77	$84.7K	269,681	SEC↗
Humes Jennifer	Chief Accounting Officer	F Tax w/h	2026-09-20	2026-09-22	3,880	$39.77	$154.3K	106,419	SEC↗
Epperly Melissa B,	Director	A Award deriv	2026-09-16	2026-09-18	10,531	—	$0	10,531	SEC↗
Fitzgerald Meghan	Director	A Award deriv	2026-09-16	2026-09-18	10,531	—	$0	10,531	SEC↗
MOMTAZEE JAMES C	Director	A Award deriv	2026-09-16	2026-09-18	10,531	—	$0	10,531	SEC↗
Oren Ilan	Director	A Award deriv	2026-09-16	2026-09-18	10,531	—	$0	10,531	SEC↗
Gold Daniel Allen	Director	A Award deriv	2026-09-16	2026-09-18	10,531	—	$0	10,531	SEC↗
MANCHESTER KEITH S	Director	A Award deriv	2026-09-16	2026-09-18	10,531	—	$0	10,531	SEC↗
Epperly Melissa B,	Director	A Award	2026-09-16	2026-09-18	5,054	—	$0	14,954	SEC↗
Fitzgerald Meghan	Director	A Award	2026-09-16	2026-09-18	5,054	—	$0	41,162	SEC↗
MOMTAZEE JAMES C	Director	A Award	2026-09-16	2026-09-18	5,054	—	$0	111,959	SEC↗
Oren Ilan	Director	A Award	2026-09-16	2026-09-18	5,054	—	$0	123,680	SEC↗
Gold Daniel Allen	Director	A Award	2026-09-16	2026-09-18	5,054	—	$0	8,965,815	SEC↗
MANCHESTER KEITH S	Director	A Award	2026-09-16	2026-09-18	5,054	—	$0	1,753,457	SEC↗
Oren Ilan	Director	A Award deriv	2026-09-16	2026-09-18	10,531	—	$0	10,531	SEC↗
Oren Ilan	Director	A Award	2026-09-16	2026-09-18	5,054	—	$0	123,680	SEC↗
MOMTAZEE JAMES C	Director	A Award deriv	2026-09-16	2026-09-18	10,531	—	$0	10,531	SEC↗
MOMTAZEE JAMES C	Director	A Award	2026-09-16	2026-09-18	5,054	—	$0	111,959	SEC↗
MANCHESTER KEITH S	Director	A Award deriv	2026-09-16	2026-09-18	10,531	—	$0	10,531	SEC↗
MANCHESTER KEITH S	Director	A Award	2026-09-16	2026-09-18	5,054	—	$0	1,753,457	SEC↗
Gold Daniel Allen	Director	A Award deriv	2026-09-16	2026-09-18	10,531	—	$0	10,531	SEC↗
Gold Daniel Allen	Director	A Award	2026-09-16	2026-09-18	5,054	—	$0	8,965,815	SEC↗
Fitzgerald Meghan	Director	A Award deriv	2026-09-16	2026-09-18	10,531	—	$0	10,531	SEC↗
Fitzgerald Meghan	Director	A Award	2026-09-16	2026-09-18	5,054	—	$0	41,162	SEC↗
Epperly Melissa B,	Director	A Award deriv	2026-09-16	2026-09-18	10,531	—	$0	10,531	SEC↗
Epperly Melissa B,	Director	A Award	2026-09-16	2026-09-18	5,054	—	$0	14,954	SEC↗
Fitzgerald Meghan	Director	S Sale	2026-09-15	2026-09-17	4,712	$39.68	$187.0K	36,508	SEC↗
Fitzgerald Meghan	Director	S Sale	2026-09-15	2026-09-17	400	$40.45	$16.2K	36,108	SEC↗
Epperly Melissa B,	Director	S Sale	2026-09-15	2026-09-17	600	$40.38	$24.2K	9,900	SEC↗
Epperly Melissa B,	Director	S Sale	2026-09-15	2026-09-17	4,338	$39.65	$172.0K	10,500	SEC↗
Fitzgerald Meghan	Director	S Sale	2026-09-15	2026-09-17	400	$40.45	$16.2K	36,108	SEC↗
Fitzgerald Meghan	Director	S Sale	2026-09-15	2026-09-17	4,712	$39.68	$187.0K	36,508	SEC↗
Epperly Melissa B,	Director	S Sale	2026-09-15	2026-09-17	600	$40.38	$24.2K	9,900	SEC↗
Epperly Melissa B,	Director	S Sale	2026-09-15	2026-09-17	4,338	$39.65	$172.0K	10,500	SEC↗
MOMTAZEE JAMES C	Director	F Tax w/h	2026-09-10	2026-09-14	2,905	$40.94	$118.9K	106,905	SEC↗
Fitzgerald Meghan	Director	F Tax w/h	2026-09-10	2026-09-14	1,743	$40.94	$71.4K	41,220	SEC↗
Epperly Melissa B,	Director	F Tax w/h	2026-09-10	2026-09-14	2,179	$40.94	$89.2K	14,838	SEC↗
Oren Ilan	Director	F Tax w/h	2026-09-10	2026-09-14	2,378	$40.94	$97.4K	118,626	SEC↗
Gold Daniel Allen	Director	F Tax w/h	2026-09-10	2026-09-14	5,133	$40.94	$210.1K	8,960,761	SEC↗
Oren Ilan	Director	F Tax w/h	2026-09-10	2026-09-14	2,378	$40.94	$97.4K	118,626	SEC↗
MOMTAZEE JAMES C	Director	F Tax w/h	2026-09-10	2026-09-14	2,905	$40.94	$118.9K	106,905	SEC↗
Gold Daniel Allen	Director	F Tax w/h	2026-09-10	2026-09-14	5,133	$40.94	$210.1K	8,960,761	SEC↗
Fitzgerald Meghan	Director	F Tax w/h	2026-09-10	2026-09-14	1,743	$40.94	$71.4K	41,220	SEC↗
Epperly Melissa B,	Director	F Tax w/h	2026-09-10	2026-09-14	2,179	$40.94	$89.2K	14,838	SEC↗
Fitzgerald Meghan	Director	M Exercise deriv	2026-09-08	2026-09-10	20,000	—	$0	18,578	SEC↗
Fitzgerald Meghan	Director	M Exercise	2026-09-08	2026-09-10	20,000	$8.80	$176.0K	62,963	SEC↗
Fitzgerald Meghan	Director	S Sale	2026-09-08	2026-09-10	20,000	$39.90	$798.0K	42,963	SEC↗
Fitzgerald Meghan	Director	M Exercise deriv	2026-09-08	2026-09-10	20,000	—	$0	18,578	SEC↗
Fitzgerald Meghan	Director	S Sale	2026-09-08	2026-09-10	20,000	$39.90	$798.0K	42,963	SEC↗
Fitzgerald Meghan	Director	M Exercise	2026-09-08	2026-09-10	20,000	$8.80	$176.0K	62,963	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise deriv	2026-08-28	2026-09-01	200,000	—	$0	3,844,834	SEC↗
Venker Eric	President & Immunovant CEO	S Sale	2026-08-28	2026-09-01	33,818	$36.44	$1.23M	1,599,154	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise	2026-08-28	2026-09-01	200,000	$3.85	$770.0K	1,799,154	SEC↗
Venker Eric	President & Immunovant CEO	S Sale	2026-08-28	2026-09-01	166,182	$35.63	$5.92M	1,632,972	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise deriv	2026-08-28	2026-09-01	200,000	—	$0	3,844,834	SEC↗
Venker Eric	President & Immunovant CEO	S Sale	2026-08-28	2026-09-01	33,818	$36.44	$1.23M	1,599,154	SEC↗
Venker Eric	President & Immunovant CEO	S Sale	2026-08-28	2026-09-01	166,182	$35.63	$5.92M	1,632,972	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise	2026-08-28	2026-09-01	200,000	$3.85	$770.0K	1,799,154	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise deriv	2026-08-21	2026-08-21	144,756	—	$0	13,224,363	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise	2026-08-21	2026-08-21	144,756	$3.85	$557.3K	18,775,495	SEC↗
Sukhatme Mayukh	President & CIO	S Sale	2026-08-21	2026-08-21	144,756	$36.48	$5.28M	18,630,739	SEC↗
Sukhatme Mayukh	President & CIO, Director	M Exercise deriv	2026-08-21	2026-08-21	144,756	—	$0	13,224,363	SEC↗
Sukhatme Mayukh	President & CIO, Director	S Sale	2026-08-21	2026-08-21	144,756	$36.48	$5.28M	18,630,739	SEC↗
Sukhatme Mayukh	President & CIO, Director	M Exercise	2026-08-21	2026-08-21	144,756	$3.85	$557.3K	18,775,495	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise deriv	2026-08-20	2026-08-21	17,519	—	$0	13,369,119	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise	2026-08-20	2026-08-21	17,519	$3.85	$67.4K	18,648,258	SEC↗
Sukhatme Mayukh	President & CIO	S Sale	2026-08-20	2026-08-21	17,519	$37.30	$653.5K	18,630,739	SEC↗
Venker Eric	President & Immunovant CEO	F Tax w/h	2026-08-20	2026-08-24	13,909	$36.84	$512.4K	1,599,154	SEC↗
Pulik Richard	CFO	F Tax w/h	2026-08-20	2026-08-24	5,749	$36.84	$211.8K	271,810	SEC↗
Sukhatme Mayukh	President & CIO, Director	M Exercise deriv	2026-08-20	2026-08-21	17,519	—	$0	13,369,119	SEC↗
Sukhatme Mayukh	President & CIO, Director	S Sale	2026-08-20	2026-08-21	17,519	$37.30	$653.5K	18,630,739	SEC↗
Sukhatme Mayukh	President & CIO, Director	M Exercise	2026-08-20	2026-08-21	17,519	$3.85	$67.4K	18,648,258	SEC↗
Venker Eric	President & Immunovant CEO	F Tax w/h	2026-08-20	2026-08-24	13,909	$36.84	$512.4K	1,599,154	SEC↗
Pulik Richard	CFO	F Tax w/h	2026-08-20	2026-08-24	5,749	$36.84	$211.8K	271,810	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise deriv	2026-08-19	2026-08-21	172,899	—	$0	13,386,638	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise	2026-08-19	2026-08-21	172,899	$3.85	$665.7K	18,803,638	SEC↗
Sukhatme Mayukh	President & CIO	S Sale	2026-08-19	2026-08-21	172,899	$37.17	$6.43M	18,630,739	SEC↗
Sukhatme Mayukh	President & CIO, Director	M Exercise deriv	2026-08-19	2026-08-21	172,899	—	$0	13,386,638	SEC↗
Sukhatme Mayukh	President & CIO, Director	S Sale	2026-08-19	2026-08-21	172,899	$37.17	$6.43M	18,630,739	SEC↗
Sukhatme Mayukh	President & CIO, Director	M Exercise	2026-08-19	2026-08-21	172,899	$3.85	$665.7K	18,803,638	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise deriv	2026-08-18	2026-08-18	136,942	—	$0	13,559,537	SEC↗
Sukhatme Mayukh	President & CIO	S Sale	2026-08-18	2026-08-18	31,801	$37.18	$1.18M	18,630,739	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise	2026-08-18	2026-08-18	31,801	$3.85	$122.4K	18,662,540	SEC↗
Sukhatme Mayukh	President & CIO	S Sale	2026-08-18	2026-08-18	105,141	$36.59	$3.85M	18,630,739	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise	2026-08-18	2026-08-18	105,141	$3.85	$404.8K	18,735,880	SEC↗
Sukhatme Mayukh	President & CIO, Director	M Exercise deriv	2026-08-18	2026-08-18	136,942	—	$0	13,559,537	SEC↗
Sukhatme Mayukh	President & CIO, Director	S Sale	2026-08-18	2026-08-18	31,801	$37.18	$1.18M	18,630,739	SEC↗
Sukhatme Mayukh	President & CIO, Director	M Exercise	2026-08-18	2026-08-18	31,801	$3.85	$122.4K	18,662,540	SEC↗
Sukhatme Mayukh	President & CIO, Director	S Sale	2026-08-18	2026-08-18	105,141	$36.59	$3.85M	18,630,739	SEC↗
Sukhatme Mayukh	President & CIO, Director	M Exercise	2026-08-18	2026-08-18	105,141	$3.85	$404.8K	18,735,880	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise deriv	2026-08-17	2026-08-18	284,707	—	$0	13,696,479	SEC↗
Sukhatme Mayukh	President & CIO	S Sale	2026-08-17	2026-08-18	284,707	$36.25	$10.32M	18,630,739	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise	2026-08-17	2026-08-18	284,707	$3.85	$1.10M	18,915,446	SEC↗
Sukhatme Mayukh	President & CIO, Director	M Exercise deriv	2026-08-17	2026-08-18	284,707	—	$0	13,696,479	SEC↗
Sukhatme Mayukh	President & CIO, Director	S Sale	2026-08-17	2026-08-18	284,707	$36.25	$10.32M	18,630,739	SEC↗
Sukhatme Mayukh	President & CIO, Director	M Exercise	2026-08-17	2026-08-18	284,707	$3.85	$1.10M	18,915,446	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise deriv	2026-08-14	2026-08-18	243,177	—	$0	13,981,186	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise	2026-08-14	2026-08-18	243,177	$3.85	$936.2K	18,873,916	SEC↗
Sukhatme Mayukh	President & CIO	S Sale	2026-08-14	2026-08-18	243,177	$36.23	$8.81M	18,630,739	SEC↗
Sukhatme Mayukh	President & CIO, Director	M Exercise deriv	2026-08-14	2026-08-18	243,177	—	$0	13,981,186	SEC↗
Sukhatme Mayukh	President & CIO, Director	S Sale	2026-08-14	2026-08-18	243,177	$36.23	$8.81M	18,630,739	SEC↗
Sukhatme Mayukh	President & CIO, Director	M Exercise	2026-08-14	2026-08-18	243,177	$3.85	$936.2K	18,873,916	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise deriv	2026-07-27	2026-07-29	200,000	—	$0	4,044,834	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise	2026-07-27	2026-07-29	200,000	$3.85	$770.0K	1,813,063	SEC↗
Venker Eric	President & Immunovant CEO	S Sale	2026-07-27	2026-07-29	200,000	$34.95	$6.99M	1,613,063	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise deriv	2026-07-27	2026-07-29	200,000	—	$0	4,044,834	SEC↗
Venker Eric	President & Immunovant CEO	S Sale	2026-07-27	2026-07-29	200,000	$34.95	$6.99M	1,613,063	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise	2026-07-27	2026-07-29	200,000	$3.85	$770.0K	1,813,063	SEC↗
Oren Ilan	Director	A Award	2026-07-17	2026-07-21	775	—	$0	121,004	SEC↗
Epperly Melissa B,	Director	A Award	2026-07-17	2026-07-21	543	—	$0	17,017	SEC↗
MOMTAZEE JAMES C	Director	A Award	2026-07-17	2026-07-21	405	—	$0	109,810	SEC↗
Fitzgerald Meghan	Director	M Exercise deriv	2026-06-30	2026-07-02	10,000	—	$0	38,578	SEC↗
Sukhatme Mayukh	President & CIO	F Tax w/h	2026-06-30	2026-07-02	46,878	$35.39	$1.66M	18,630,739	SEC↗
Torti Frank	President and Vant Chair	F Tax w/h	2026-06-30	2026-07-02	40,310	$35.39	$1.43M	13,536,202	SEC↗
Fitzgerald Meghan	Director	S Sale	2026-06-30	2026-07-02	10,000	$34.90	$349.0K	42,963	SEC↗
Fitzgerald Meghan	Director	M Exercise	2026-06-30	2026-07-02	10,000	$8.80	$88.0K	52,963	SEC↗
Gline Matthew	CEO	F Tax w/h	2026-06-30	2026-07-02	76,171	$35.39	$2.70M	16,659,945	SEC↗
QVT Financial LP	Other	S Sale	2026-06-30	2026-06-30	12,380	$35.28	$436.8K	13,689,166	SEC↗
Gold Daniel Allen	Director	S Sale	2026-06-30	2026-06-30	12,380	$35.28	$436.8K	13,689,166	SEC↗
MANCHESTER KEITH S	Director	S Sale	2026-06-30	2026-06-30	12,380	$35.28	$436.8K	13,689,166	SEC↗
MANCHESTER KEITH S	Director	S Sale	2026-06-30	2026-06-30	200,000	$35.45	$7.09M	1,748,403	SEC↗
Epperly Melissa B,	Director	M Exercise deriv	2026-06-29	2026-07-01	17,750	—	$0	169,166	SEC↗
Epperly Melissa B,	Director	S Sale	2026-06-29	2026-07-01	15,002	$34.32	$514.9K	19,222	SEC↗
Epperly Melissa B,	Director	S Sale	2026-06-29	2026-07-01	2,748	$34.71	$95.4K	16,474	SEC↗
Epperly Melissa B,	Director	M Exercise	2026-06-29	2026-07-01	17,750	$4.46	$79.2K	34,224	SEC↗
QVT Financial LP	Other	S Sale	2026-06-29	2026-06-30	200,000	$34.44	$6.89M	14,301,546	SEC↗
QVT Financial LP	Other	S Sale	2026-06-29	2026-06-30	600,000	$34.59	$20.75M	13,701,546	SEC↗
Gold Daniel Allen	Director	S Sale	2026-06-29	2026-06-30	600,000	$34.59	$20.75M	13,701,546	SEC↗
Gold Daniel Allen	Director	S Sale	2026-06-29	2026-06-30	200,000	$34.44	$6.89M	14,301,546	SEC↗
MANCHESTER KEITH S	Director	S Sale	2026-06-29	2026-06-30	200,000	$34.44	$6.89M	14,301,546	SEC↗
MANCHESTER KEITH S	Director	S Sale	2026-06-29	2026-06-30	600,000	$34.59	$20.75M	13,701,546	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise deriv	2026-06-26	2026-06-29	500,000	—	$0	14,224,363	SEC↗
Sukhatme Mayukh	President & CIO	S Sale	2026-06-26	2026-06-29	500,000	$34.08	$17.04M	18,677,617	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise	2026-06-26	2026-06-29	500,000	$3.85	$1.93M	19,177,617	SEC↗
QVT Financial LP	Other	S Sale	2026-06-26	2026-06-30	300,783	$33.92	$10.20M	14,826,546	SEC↗
QVT Financial LP	Other	S Sale	2026-06-26	2026-06-30	325,000	$34.07	$11.07M	14,501,546	SEC↗
Gold Daniel Allen	Director	S Sale	2026-06-26	2026-06-30	300,783	$33.92	$10.20M	14,826,546	SEC↗
Gold Daniel Allen	Director	S Sale	2026-06-26	2026-06-30	325,000	$34.07	$11.07M	14,501,546	SEC↗
MANCHESTER KEITH S	Director	S Sale	2026-06-26	2026-06-30	300,783	$33.92	$10.20M	14,826,546	SEC↗
MANCHESTER KEITH S	Director	S Sale	2026-06-26	2026-06-30	325,000	$34.07	$11.07M	14,501,546	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise deriv	2026-06-25	2026-06-29	500,000	—	$0	14,724,363	SEC↗
Sukhatme Mayukh	President & CIO	S Sale	2026-06-25	2026-06-29	500,000	$34.13	$17.07M	18,677,617	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise	2026-06-25	2026-06-29	500,000	$3.85	$1.93M	19,177,617	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise deriv	2026-06-24	2026-06-26	200,000	—	$0	4,244,834	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise	2026-06-24	2026-06-26	200,000	$3.85	$770.0K	1,813,063	SEC↗
Venker Eric	President & Immunovant CEO	S Sale	2026-06-24	2026-06-26	153,766	$33.05	$5.08M	1,659,297	SEC↗
Venker Eric	President & Immunovant CEO	S Sale	2026-06-24	2026-06-26	46,234	$33.51	$1.55M	1,613,063	SEC↗
Humes Jennifer	Chief Accounting Officer	F Tax w/h	2026-06-20	2026-06-23	3,582	$31.43	$112.6K	109,782	SEC↗
Pulik Richard	CFO	F Tax w/h	2026-06-20	2026-06-23	2,129	$31.43	$66.9K	276,420	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise deriv	2026-05-22	2026-05-22	200,000	—	$0	4,444,834	SEC↗
Venker Eric	President & Immunovant CEO	S Sale	2026-05-22	2026-05-22	200,000	$30.27	$6.05M	1,613,063	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise	2026-05-22	2026-05-22	200,000	$3.85	$770.0K	1,813,063	SEC↗
Pulik Richard	CFO	F Tax w/h	2026-05-20	2026-05-22	18,962	$32.41	$614.6K	278,549	SEC↗
Venker Eric	President & Immunovant CEO	F Tax w/h	2026-05-20	2026-05-22	34,483	$32.41	$1.12M	1,613,063	SEC↗
Humes Jennifer	Chief Accounting Officer	A Award deriv	2026-04-20	2026-04-22	27,157	—	$0	27,157	SEC↗
Pulik Richard	CFO	A Award deriv	2026-04-20	2026-04-22	84,026	—	$0	84,026	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise deriv	2026-04-20	2026-04-22	200,000	—	$0	4,644,834	SEC↗
Humes Jennifer	Chief Accounting Officer	A Award	2026-04-20	2026-04-22	29,173	—	$0	113,364	SEC↗
Pulik Richard	CFO	A Award	2026-04-20	2026-04-22	60,644	—	$0	297,511	SEC↗
Venker Eric	President & Immunovant CEO	S Sale	2026-04-20	2026-04-22	200,000	$29.59	$5.92M	1,647,546	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise	2026-04-20	2026-04-22	200,000	$3.85	$770.0K	1,847,546	SEC↗
MOMTAZEE JAMES C	Director	A Award	2026-04-17	2026-04-21	469	—	$0	109,499	SEC↗
MOMTAZEE JAMES C	Director	F Tax w/h	2026-04-17	2026-04-21	94	$29.83	$2.8K	109,405	SEC↗
Epperly Melissa B,	Director	A Award	2026-04-17	2026-04-21	670	—	$0	16,474	SEC↗
Oren Ilan	Director	F Tax w/h	2026-04-17	2026-04-21	95	$29.83	$2.8K	120,229	SEC↗
Oren Ilan	Director	A Award	2026-04-17	2026-04-21	896	—	$0	120,324	SEC↗
Gline Matthew	CEO	S Sale	2026-04-16	2026-04-20	289,774	$29.16	$8.45M	16,736,116	SEC↗
Humes Jennifer	Chief Accounting Officer	S Sale	2026-04-08	2026-04-10	13,538	$28.37	$384.1K	84,191	SEC↗
Sukhatme Mayukh	President & CIO	F Tax w/h	2026-03-31	2026-04-01	187,512	$27.70	$5.19M	18,677,617	SEC↗
Gline Matthew	CEO	F Tax w/h	2026-03-31	2026-04-01	304,684	$27.70	$8.44M	17,025,890	SEC↗
Torti Frank	President and Vant Chair	F Tax w/h	2026-03-31	2026-04-02	160,035	$27.70	$4.43M	13,576,512	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise deriv	2026-03-30	2026-04-01	1,306,889	$11.50	$15.03M	0	SEC↗
Gline Matthew	CEO	M Exercise deriv	2026-03-30	2026-04-01	2,178,150	$11.50	$25.05M	0	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise	2026-03-30	2026-04-01	58,391	—	$0	18,894,938	SEC↗
Sukhatme Mayukh	President & CIO	F Tax w/h	2026-03-30	2026-04-01	29,809	$26.41	$787.3K	18,865,129	SEC↗
Gline Matthew	CEO	F Tax w/h	2026-03-30	2026-04-01	53,826	$26.41	$1.42M	17,330,574	SEC↗
Gline Matthew	CEO	M Exercise	2026-03-30	2026-04-01	97,319	—	$0	17,384,400	SEC↗
Fitzgerald Meghan	Director	M Exercise deriv	2026-03-26	2026-03-30	70,000	—	$0	48,578	SEC↗
Fitzgerald Meghan	Director	S Sale	2026-03-26	2026-03-30	70,000	$27.45	$1.92M	42,963	SEC↗
Fitzgerald Meghan	Director	M Exercise	2026-03-26	2026-03-30	70,000	$8.80	$616.0K	112,963	SEC↗
Humes Jennifer	Chief Accounting Officer	F Tax w/h	2026-03-20	2026-03-24	14,526	$27.70	$402.4K	97,729	SEC↗
Pulik Richard	CFO	F Tax w/h	2026-03-20	2026-03-24	1,546	$27.70	$42.8K	236,867	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise deriv	2026-03-17	2026-03-19	200,000	—	$0	4,844,834	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise	2026-03-17	2026-03-19	200,000	$3.85	$770.0K	1,847,546	SEC↗
Venker Eric	President & Immunovant CEO	S Sale	2026-03-17	2026-03-19	200,000	$28.24	$5.65M	1,647,546	SEC↗
Epperly Melissa B,	Director	S Sale	2026-03-16	2026-03-18	41,861	$28.68	$1.20M	15,804	SEC↗
Torti Frank	President and Vant Chair	M Exercise deriv	2026-02-23	2026-02-23	587,390	—	$0	3,026,184	SEC↗
Torti Frank	President and Vant Chair	S Sale	2026-02-23	2026-02-23	587,390	$27.51	$16.16M	13,736,547	SEC↗
Torti Frank	President and Vant Chair	M Exercise	2026-02-23	2026-02-23	587,390	$3.85	$2.26M	14,323,937	SEC↗
Torti Frank	President and Vant Chair	M Exercise deriv	2026-02-20	2026-02-23	1,012,610	—	$0	3,613,574	SEC↗
Torti Frank	President and Vant Chair	S Sale	2026-02-20	2026-02-23	1,012,610	$27.15	$27.49M	13,736,547	SEC↗
Torti Frank	President and Vant Chair	M Exercise	2026-02-20	2026-02-23	1,012,610	$3.85	$3.90M	14,749,157	SEC↗
Venker Eric	President & Immunovant CEO	F Tax w/h	2026-02-20	2026-02-24	7,051	$27.15	$191.4K	1,647,546	SEC↗
Pulik Richard	CFO	F Tax w/h	2026-02-20	2026-02-24	1,000	$27.15	$27.1K	238,413	SEC↗
Torti Frank	President and Vant Chair	M Exercise deriv	2026-02-19	2026-02-23	1,400,000	—	$0	4,626,184	SEC↗
Torti Frank	President and Vant Chair	S Sale	2026-02-19	2026-02-23	1,400,000	$27.42	$38.39M	13,736,547	SEC↗
Torti Frank	President and Vant Chair	M Exercise	2026-02-19	2026-02-23	1,400,000	$3.85	$5.39M	15,136,547	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise deriv	2026-02-13	2026-02-18	200,000	—	$0	5,044,834	SEC↗
QVT Financial LP	Other	S Sale	2026-02-13	2026-02-13	150,784	$26.49	$3.99M	15,352,329	SEC↗
QVT Financial LP	Other	S Sale	2026-02-13	2026-02-13	225,000	$26.50	$5.96M	15,127,329	SEC↗
Gold Daniel Allen	Director	S Sale	2026-02-13	2026-02-13	150,784	$26.49	$3.99M	15,352,329	SEC↗
Gold Daniel Allen	Director	S Sale	2026-02-13	2026-02-13	225,000	$26.50	$5.96M	15,127,329	SEC↗
MANCHESTER KEITH S	Director	S Sale	2026-02-13	2026-02-13	225,000	$26.50	$5.96M	15,127,329	SEC↗
MANCHESTER KEITH S	Director	S Sale	2026-02-13	2026-02-13	150,784	$26.49	$3.99M	15,352,329	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise	2026-02-13	2026-02-18	200,000	$3.85	$770.0K	1,854,597	SEC↗
Venker Eric	President & Immunovant CEO	S Sale	2026-02-13	2026-02-18	200,000	$26.49	$5.30M	1,654,597	SEC↗
QVT Financial LP	Other	S Sale	2026-02-12	2026-02-13	275,000	$26.76	$7.36M	15,503,113	SEC↗
QVT Financial LP	Other	S Sale	2026-02-12	2026-02-13	150,000	$26.72	$4.01M	15,778,113	SEC↗
Gold Daniel Allen	Director	S Sale	2026-02-12	2026-02-13	275,000	$26.76	$7.36M	15,503,113	SEC↗
Gold Daniel Allen	Director	S Sale	2026-02-12	2026-02-13	150,000	$26.72	$4.01M	15,778,113	SEC↗
MANCHESTER KEITH S	Director	S Sale	2026-02-12	2026-02-13	150,000	$26.72	$4.01M	15,778,113	SEC↗
MANCHESTER KEITH S	Director	S Sale	2026-02-12	2026-02-13	275,000	$26.76	$7.36M	15,503,113	SEC↗
QVT Financial LP	Other	S Sale	2026-02-11	2026-02-13	425,000	$26.67	$11.33M	15,928,113	SEC↗
Gold Daniel Allen	Director	S Sale	2026-02-11	2026-02-13	425,000	$26.67	$11.33M	15,928,113	SEC↗
MANCHESTER KEITH S	Director	S Sale	2026-02-11	2026-02-13	425,000	$26.67	$11.33M	15,928,113	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise deriv	2026-02-09	2026-02-11	651,558	—	$0	0	SEC↗
Sukhatme Mayukh	President & CIO	J Other	2026-02-09	2026-02-11	312,117	$26.47	$8.26M	18,836,547	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise	2026-02-09	2026-02-11	651,558	$12.68	$8.26M	19,488,105	SEC↗
Sukhatme Mayukh	President & CIO	S Sale	2026-02-09	2026-02-11	339,441	$26.47	$8.99M	19,148,664	SEC↗
Epperly Melissa B,	Director	A Award	2026-01-20	2026-01-22	815	—	$0	57,719	SEC↗
Epperly Melissa B,	Director	F Tax w/h	2026-01-20	2026-01-22	54	$22.98	$1.2K	57,665	SEC↗
Oren Ilan	Director	F Tax w/h	2026-01-20	2026-01-22	124	$22.98	$2.8K	119,428	SEC↗
Oren Ilan	Director	A Award	2026-01-20	2026-01-22	1,164	—	$0	119,552	SEC↗
MOMTAZEE JAMES C	Director	A Award	2026-01-20	2026-01-22	609	—	$0	109,152	SEC↗
MOMTAZEE JAMES C	Director	F Tax w/h	2026-01-20	2026-01-22	122	$22.98	$2.8K	109,030	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise deriv	2026-01-12	2026-01-14	200,000	—	$0	5,244,834	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise	2026-01-12	2026-01-14	200,000	$3.85	$770.0K	1,854,597	SEC↗
Venker Eric	President & Immunovant CEO	S Sale	2026-01-12	2026-01-14	200,000	$21.92	$4.38M	1,654,597	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise deriv	2025-12-31	2025-12-31	2,449,877	—	$0	95,718	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise	2025-12-31	2025-12-31	2,449,877	$12.68	$31.06M	21,286,424	SEC↗
Sukhatme Mayukh	President & CIO	S Sale	2025-12-31	2025-12-31	1,018,995	$21.71	$22.12M	20,267,429	SEC↗
Sukhatme Mayukh	President & CIO	J Other	2025-12-31	2025-12-31	1,430,882	$21.71	$31.06M	18,836,547	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise deriv	2025-12-29	2025-12-31	748,358	—	$0	555,840	SEC↗
Sukhatme Mayukh	President & CIO	J Other	2025-12-29	2025-12-31	436,485	$21.74	$9.49M	18,836,547	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise	2025-12-29	2025-12-31	748,358	$12.68	$9.49M	19,584,905	SEC↗
Sukhatme Mayukh	President & CIO	S Sale	2025-12-29	2025-12-31	311,873	$21.74	$6.78M	19,273,032	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise deriv	2025-12-24	2025-12-29	117,848	—	$0	5,444,834	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise	2025-12-24	2025-12-29	117,848	$3.85	$453.7K	1,729,597	SEC↗
Venker Eric	President & Immunovant CEO	S Sale	2025-12-24	2025-12-29	75,000	$22.53	$1.69M	1,654,597	SEC↗
Torti Frank	President and Vant Chair	G Gift	2025-12-24	2025-12-29	110,489	—	$0	13,736,547	SEC↗
Torti Frank	President and Vant Chair	J Other	2025-12-24	2025-12-29	64,891	$22.47	$1.46M	13,847,036	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise deriv	2025-12-23	2025-12-29	313,841	—	$0	5,562,682	SEC↗
Pulik Richard	CFO	M Exercise deriv	2025-12-23	2025-12-29	260,000	—	$0	740,000	SEC↗
Venker Eric	President & Immunovant CEO	M Exercise	2025-12-23	2025-12-29	313,841	$3.85	$1.21M	1,811,749	SEC↗
Venker Eric	President & Immunovant CEO	S Sale	2025-12-23	2025-12-29	200,000	$22.45	$4.49M	1,611,749	SEC↗
Pulik Richard	CFO	M Exercise	2025-12-23	2025-12-29	260,000	$3.85	$1.00M	646,144	SEC↗
Pulik Richard	CFO	S Sale	2025-12-23	2025-12-29	260,000	$22.45	$5.84M	386,144	SEC↗
Pulik Richard	CFO	S Sale	2025-12-23	2025-12-29	146,731	$22.39	$3.29M	239,413	SEC↗
Torti Frank	President and Vant Chair	A Award	2025-12-23	2025-12-29	175,380	$22.45	$3.94M	13,911,927	SEC↗
Pulik Richard	CFO	F Tax w/h	2025-12-20	2025-12-23	2,129	$22.41	$47.7K	386,144	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise deriv	2025-12-17	2025-12-19	59,513	—	$0	1,304,198	SEC↗
QVT Financial LP	Other	S Sale	2025-12-17	2025-12-18	155,076	$23.02	$3.57M	16,542,651	SEC↗
QVT Financial LP	Other	S Sale	2025-12-17	2025-12-18	189,538	$23.17	$4.39M	16,353,113	SEC↗
QVT Financial LP	Other	S Sale	2025-12-17	2025-12-18	432,718	$23.05	$9.97M	16,697,727	SEC↗
MANCHESTER KEITH S	Director	S Sale	2025-12-17	2025-12-18	155,076	$23.02	$3.57M	16,542,651	SEC↗
MANCHESTER KEITH S	Director	S Sale	2025-12-17	2025-12-18	432,718	$23.05	$9.97M	16,697,727	SEC↗
MANCHESTER KEITH S	Director	S Sale	2025-12-17	2025-12-18	189,538	$23.17	$4.39M	16,353,113	SEC↗
Gold Daniel Allen	Director	S Sale	2025-12-17	2025-12-18	432,718	$23.05	$9.97M	16,697,727	SEC↗
Gold Daniel Allen	Director	S Sale	2025-12-17	2025-12-18	155,076	$23.02	$3.57M	16,542,651	SEC↗
Gold Daniel Allen	Director	S Sale	2025-12-17	2025-12-18	189,538	$23.17	$4.39M	16,353,113	SEC↗
Sukhatme Mayukh	President & CIO	M Exercise	2025-12-17	2025-12-19	59,513	$12.68	$754.6K	18,896,060	SEC↗
Sukhatme Mayukh	President & CIO	S Sale	2025-12-17	2025-12-19	26,831	$23.09	$619.5K	18,869,229	SEC↗
Sukhatme Mayukh	President & CIO	J Other	2025-12-17	2025-12-19	32,682	$23.09	$754.6K	18,836,547	SEC↗
QVT Financial LP	Other	S Sale	2025-12-16	2025-12-18	275,000	$22.93	$6.31M	17,772,727	SEC↗
QVT Financial LP	Other	S Sale	2025-12-16	2025-12-18	642,282	$23.08	$14.82M	17,130,445	SEC↗
MANCHESTER KEITH S	Director	S Sale	2025-12-16	2025-12-18	642,282	$23.08	$14.82M	17,130,445	SEC↗
MANCHESTER KEITH S	Director	S Sale	2025-12-16	2025-12-18	275,000	$22.93	$6.31M	17,772,727	SEC↗
Gold Daniel Allen	Director	S Sale	2025-12-16	2025-12-18	275,000	$22.93	$6.31M	17,772,727	SEC↗
Gold Daniel Allen	Director	S Sale	2025-12-16	2025-12-18	642,282	$23.08	$14.82M	17,130,445	SEC↗
Ramaswamy Vivek	10% Owner	M Exercise deriv	2025-12-15	2025-12-15	832,453	—	$0	22,150,227	SEC↗
Gline Matthew	CEO	M Exercise deriv	2025-12-15	2025-12-17	1,363,711	—	$0	0	SEC↗
Gline Matthew	CEO	M Exercise deriv	2025-12-15	2025-12-17	234,096	—	$0	0	SEC↗
Gline Matthew	CEO	M Exercise deriv	2025-12-15	2025-12-17	2,272,852	—	$0	0	SEC↗
Ramaswamy Vivek	10% Owner	S Sale	2025-12-15	2025-12-15	353,745	$22.05	$7.80M	34,132,463	SEC↗
Ramaswamy Vivek	10% Owner	M Exercise	2025-12-15	2025-12-15	832,453	$12.68	$10.56M	34,486,208	SEC↗
Ramaswamy Vivek	10% Owner	J Other	2025-12-15	2025-12-15	478,708	$22.05	$10.56M	33,653,755	SEC↗
Gline Matthew	CEO	J Other	2025-12-15	2025-12-17	1,329,325	$21.68	$28.82M	17,287,081	SEC↗
Gline Matthew	CEO	J Other	2025-12-15	2025-12-17	797,595	$21.68	$17.29M	17,287,081	SEC↗